从效率到产量:探索CHO细胞系开发对单克隆抗体的最新进展
Sarmishta Majumdar1, Ranjeet Desai2, Aakarsh Hans2
1Department of Biological Science and Biotechnology, Institute of Chemical Technology, Mumbai, 400019, India.
Molecular biotechnology
|February 16, 2024
概括
开发稳定,高生产单克隆抗体 (mAbs) 的细胞系至关重要. 本综述强调了细胞系发展的进步,以满足对一致,高质量的治疗蛋白质日益增长的需求.
科学领域:
- 生物技术是生物技术.
- 生物制药制造业 生物制药制造业
- 蛋白质表达方式
背景情况:
- 对生物类似单克隆抗体 (mAbs) 的需求需要有效和稳定的细胞系发展.
- 当前的平台通常在mAb生产中产生不一致的结果,影响产品质量和产量.
- 优化表达系统和细胞系的生成对于重组蛋白质合成至关重要.
研究的目的:
- 审查最近在加速细胞系发育治疗性蛋白质生产方面的进展.
- 解决目前用于单克隆抗体合成的平台的低效性.
- 为了弥合日益增长的需求和一致的,高质量的mAb生产之间的差距.
主要方法:
- 探索最近在表达系统设计方面的突破.
- 简化细胞系生成方法的分析.
- 优化培养条件和净化策略的审查.
主要成果:
- 确定提高细胞系稳定性和生产力的关键策略.
- 突出方法以提高mAb产量和质量属性的一致性.
- 专注于加速整体细胞系发育时间表.
结论:
- 细胞系发展的进步对于满足治疗性单克隆抗体的需求至关重要.
- 精简和优化方法确保一致的,高质量的生产.
- 改善细胞系发育有利于制药和医疗保健行业.
相关概念视频
01:31Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
01:16Cell Lines
7.4K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
7.4K